VANCOUVER, BC, Feb. 3, 2022 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology for mental health care and research in psychedelics, announced today the hiring of Dr. Clare Purvis, formerly Headspace Inc.’s Vice President of Clinical Product and Content Development, for the Company’s newly created role of…


Previous articleSmall Pharma Reports Fiscal Third Quarter 2021 Highlights
Next articleSilo Pharma Extends Exclusive Option Agreement for Homing Peptides